Well, to be fair, it hasnt been that long since the last CR. While it makes sense to raise after FDA approval and today's overdone and shortsighted reaction is disappointing, it is unsurprising that there was a sell-down, imo. We are unlikely to be on too many people's EOFY sell-off list but there is that factor in June as well.
All that said, I hope the less skitish and capricious among us will be rewarded with further positive newsflow in the coming months. GLTA no matter your strategy.
Add to My Watchlist
What is My Watchlist?
